Related Experiment Video
Updated: May 25, 2026
09:45
A Protocol for Safe Lithiation Reactions Using Organolithium Reagents
Published on: November 12, 2016
Management of Lithium in Pregnancy and Lactation: An Individualized Approach
Hannah K Betcher1, Alexandra Vydysh2, Brittany D Ellington3
1Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
Current Psychiatry Reports
|May 23, 2026
Summary
Lithium is a safe and effective treatment for bipolar disorder (BD) during pregnancy and lactation. Careful monitoring and individualized dosing ensure maternal and infant well-being.
Area of Science:
- Reproductive Psychiatry
- Pharmacotherapy
- Mood Disorders
Background:
- Bipolar disorder (BD) is a chronic illness affecting 4% of the population, with women vulnerable during reproductive years.
- Peripartum hormonal changes increase the risk of mood episodes in women with BD.
- Fear and misunderstanding surrounding lithium use in pregnancy and lactation lead to treatment discontinuation or undertreatment.
Purpose of the Study:
- To review data on lithium use during pregnancy and lactation.
- To optimize management strategies for bipolar disorder in pregnant and lactating individuals.
- To address fears and misunderstandings regarding lithium therapy in the peripartum period.
Main Methods:
- Literature review of studies on lithium use in pregnancy and lactation.
- Analysis of data on mood episode risk and treatment outcomes.
- Focus on individualized patient management approaches.
Main Results:
- Lithium is a viable treatment option throughout the peripartum period, including lactation.
- Dose adjustments and enhanced monitoring are essential for safe lithium use.
- Patients stable on lithium can continue treatment during pregnancy with personalized care.
Conclusions:
- Lithium can be safely continued during pregnancy and lactation for women with bipolar disorder.
- An individualized approach to dosing and monitoring is crucial for optimal outcomes.
- Continued pharmacotherapy with lithium supports emotional wellness in peripartum women with BD.
Related Concept Videos
01:24Mania and Antimanic Drugs: Overview
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:21Factors Affecting Drug Response: Overview
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:25Dysrhythmias VII: Nursing Management of Dysrhythmias
Nursing management of dysrhythmias involves the following:AssessmentSubjective Assessment:The initial step involves gathering patient-reported symptoms such as dizziness, palpitations, and chest discomfort. It is crucial to collect a detailed history, including previous heart conditions, current medication use, and lifestyle factors like caffeine and alcohol consumption.Objective Assessment:This involves observing clinical signs such as jugular venous distention, cool and pale skin, and...